logo

For the Inventor, By the Inventor

Ober-Ramstadt, Germany

Klaus Otto Minck

This inventor holds 14 USPTO granted patents. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1979-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Otto Minck. Retrieved from https://idiyas.com/inventor/klaus-otto-minck-rvr7raz6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 82(Granted Patents)


Location History:

  • Darmstadt, DE (1979 - 1981)
  • Ober-Ramstadt, DE (1981 - 2000)

Company Filing History:

goldMedal14 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents

Years Active: 1979-2000

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6022883 - Heterocyclyloxybenzoylguanidines (2000-02-08),
2. 5215967 - Aminoacid derivatives inhibiting renin (1993-06-01),
3. 5215966 - Peptide and renin inhibitors (1993-06-01),
4. 5104881 - 2-arylimidazopyridines (1992-04-14),
5. 4829053 - Amino acid derivatives (1989-05-09),
6. 4812555 - Peptides possessing renin inhibitory activity (1989-03-14),
7. 4780478 - Aminopropoxy-chromones useful as antidepressants (1988-10-25),
8. 4721776 - Amino acid derivatives (1988-01-26),
9. 4508732 - Basic ethers useful as antidepressant agents (1985-04-02),
10. 4376123 - Hexahydroazepinyloxy-chromones useful as antidepressants (1983-03-08),
11. 4288452 - 1-Aryloxy-3-nitratoalkylamino-2-propanols and use as .beta.-receptor (1981-09-08),
12. 4258062 - Phenoxy-amino-propanols (1981-03-24),
13. 4258047 - Pyrazole derivatives, pharmaceutical formulations thereof (1981-03-24),
14. 4171370 - Phenoxy-amino-propanols (1979-10-16),

Title: Klaus Otto Minck: Innovator in Pharmaceutical Chemistry

Introduction

Klaus Otto Minck is a distinguished inventor based in Ober-Ramstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 14 patents to his name, Minck's work has had a notable impact on medical science.

Latest Patents

Among his latest patents are innovative compounds such as Heterocyclyloxybenzoylguanidines. These compounds exhibit antiarrhythmic properties and act as inhibitors of the cellular Na+/H+ antiporter. Another significant patent involves amino acid derivatives that inhibit renin, showcasing his commitment to advancing pharmaceutical research.

Career Highlights

Klaus Otto Minck is currently associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a focus on developing new therapeutic agents that address critical health issues.

Collaborations

Throughout his career, Minck has collaborated with notable colleagues, including Peter Raddatz and Claus J Schmitges. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research.

Conclusion

Klaus Otto Minck's contributions to pharmaceutical chemistry are marked by his innovative patents and collaborative efforts. His work continues to influence the development of new therapeutic agents, underscoring his importance in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…